Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the area of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and gene editing are revolutionizing the outlook for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering promise for more curative treatm